Stiefel Sues Cobrek, Perrigo Over Generic Acne Drug
In a complaint filed Friday in the U.S. District Court for the District of Delaware, Stiefel and its Australian research subsidiary, Stiefel Research Australia Pty. Ltd., allege Cobrek and Perrigo have infringed its patents by filing an abbreviated new drug application with the U.S. Food and Drug...
To view the full article, register now.
Try Law360 FREE for seven days
Already a subscriber? Click here to login